FINORGA SAS

FINORGA SAS (France) holds 3 active US FDA Type II Drug Master Files and 20 inactive, has DMF or CEP filings on record for 14 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “FINORGA SAS: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/finorga-sas

Overview

FINORGA SAS is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering ADAPALENE; ESMOLOL HYDROCHLORIDE; ICOSAPENT ETHYL.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which FINORGA SAS holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

FINORGA SAS holds 3 active (23 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ICOSAPENT ETHYLActive2013-05-23
  • ADAPALENEActive1990-10-12
  • ESMOLOL HYDROCHLORIDEActive1987-01-20
  • FENOFIBRATEInactive2011-10-28
  • TMC 125Inactive2001-10-24
  • CRE16336Inactive2001-05-17
  • TIAPRIDE HYDROCHLORIDEInactive1998-12-02
  • LEVOBETAXOLOL HYDROCHLORIDEInactive1998-10-19
  • N-(2-DEOXY-2-L-LEUCYLAMINO-B-D-GLUCOPYRANOSYL)-N-OCTADECYL-DODECANAMIDEInactive1997-11-13
  • 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYLURACILInactive1997-08-14
  • ALFUZOSIN HYDROCHLORIDEInactive1997-06-03
  • ZOLPIDEM TARTRATE MODIFIED SYNTHESISInactive1995-12-05
  • RITONAVIRInactive1995-09-11
  • PHENYLOXYCARBONYL-(L)-VALINE METHYL ESTERInactive1995-03-30
  • 2-BUTYL-4(5)-CHLORO-1H-IMIDAZOLE-5(4)-CARBOXALDEHYDEInactive1993-08-27
  • (-)-(R)-1,2,3,4,-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-1-(3,4,5-TRIMETHOXYBENZYL) ISOQUINOLINE 2,3-DI-O-BENZOYL-L-TARTRATEInactive1990-01-26
  • 6-METHOXY-2-NAPHTHALDEHYDEInactive1988-05-20
  • BETAXOLOL HYDROCHLORIDEInactive1986-03-04
  • TOLRESTATInactive1985-08-30
  • 6-METHOXY 5, TRIFLUOROMETHYL 1-NAPHTHOLIC ACIDInactive1985-08-30
  • METHYL SARCOSINATE HClInactive1985-08-30
  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CHASSE-SUR-RHONE, FRANCE.Inactive1985-04-24
  • TRITHIOZINEInactive1979-08-22

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to FINORGA SAS, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FINORGA SAS in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this FINORGA SAS?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.